Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Nathalie Roxanne Javidi-Sharifi, M.D., Ph.D.

Concepts (62)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Nathalie Javidi-Sharifi's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Nathalie Javidi-Sharifi has written about over time.
Receptor, Fibroblast Growth Factor, Type 3, 2 publications between 2014 and 2014, average publication date June 2014. Receptor Cross-Talk, 1 publications between 2014 and 2014, average publication date November 2014. GTP-Binding Protein beta Subunits, 1 publications between 2014 and 2014, average publication date December 2014. Drug Resistance, Neoplasm, 4 publications between 2014 and 2018, average publication date August 2015. Fibroblast Growth Factor 2, 3 publications between 2014 and 2019, average publication date August 2016. Gastrointestinal Stromal Tumors, 2 publications between 2014 and 2018, average publication date October 2016. Proto-Oncogene Proteins c-kit, 2 publications between 2014 and 2018, average publication date October 2016. Protein Kinase Inhibitors, 5 publications between 2014 and 2021, average publication date November 2016. Antineoplastic Agents, 2 publications between 2014 and 2021, average publication date November 2017. Leukemia, Myeloid, Acute, 2 publications between 2016 and 2019, average publication date November 2017. Signal Transduction, 3 publications between 2014 and 2023, average publication date November 2018. Exosomes, 1 publications between 2019 and 2019, average publication date February 2019. Mesenchymal Stem Cells, 1 publications between 2019 and 2019, average publication date February 2019. Receptor, Fibroblast Growth Factor, Type 1, 1 publications between 2019 and 2019, average publication date February 2019. Antineoplastic Combined Chemotherapy Protocols, 1 publications between 2021 and 2021, average publication date October 2021. Leukemia, Myeloid, Chronic-Phase, 1 publications between 2021 and 2021, average publication date October 2021. Niacinamide, 1 publications between 2021 and 2021, average publication date October 2021. Phosphatidylinositol 3-Kinases, 1 publications between 2023 and 2023, average publication date August 2023.

To see the data from this visualization as text, click here.
Javidi-Sharifi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (62)
Explore
_
Co-Authors (9)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.